Literature DB >> 12358503

In vitro fermentability of differently substituted xylo-oligosaccharides.

Mirjam A Kabel1, Linda Kortenoeven, Henk A Schols, Alphons G J Voragen.   

Abstract

Xylo-oligosaccharides (XOS) with various substituents were fermented in vitro by fecal inocula (FI) from four human volunteers to study the influence of substitution on the ability and rate of fermentation and on the production of short-chain fatty acids (SCFA) and lactate. By all FI used nonsubstituted XOS (nXOS) and arabino-XOS (AXOS) were fermented more quickly than the more complex structures of acetylated XOS (AcXOS) and XOS containing a 4-O-methylglucuronic acid group (GlcA(me)XOS). In the first stage (0-40 h) of the fermentations of nXOS and AXOS mainly acetate and lactate were formed. The fermentations of AcXOS and GlcA(me)XOS resulted in a lower lactate production, whereas the concentration of propionate and butyrate increased. These results put emphasis on the detailed elucidation of the structural features of nondigestible oligosaccharides in general to understand their fermentation mechanisms more precisely.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358503     DOI: 10.1021/jf020220r

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  20 in total

Review 1.  The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes.

Authors:  Eric C Martens; Amelia G Kelly; Alexandra S Tauzin; Harry Brumer
Journal:  J Mol Biol       Date:  2014-07-12       Impact factor: 5.469

2.  High-Throughput Generation of Product Profiles for Arabinoxylan-Active Enzymes from Metagenomes.

Authors:  Maria João Maurício da Fonseca; Zachary Armstrong; Stephen G Withers; Yves Briers
Journal:  Appl Environ Microbiol       Date:  2020-11-10       Impact factor: 4.792

3.  Lactobacillus rhamnosus JCM 2771: impact on metabolism of isoflavonoids in the fecal flora from a male equol producer.

Authors:  Motoi Tamura; Sachiko Hori; Hiroyuki Nakagawa
Journal:  Curr Microbiol       Date:  2011-03-02       Impact factor: 2.188

4.  Non-Alcoholic Beverages from Fermented Cereals with Increased Oligosaccharide Content.

Authors:  Loreta Basinskiene; Grazina Juodeikiene; Daiva Vidmantiene; Maija Tenkanen; Tomas Makaravicius; Elena Bartkiene
Journal:  Food Technol Biotechnol       Date:  2016-03       Impact factor: 3.918

5.  Delineating thermophilic xylanase from Bacillus licheniformis DM5 towards its potential application in xylooligosaccharides production.

Authors:  Arabinda Ghosh; Saikat Sutradhar; Debabrat Baishya
Journal:  World J Microbiol Biotechnol       Date:  2019-01-31       Impact factor: 3.312

6.  Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide.

Authors:  Rina González; Eline S Klaassens; Erja Malinen; Willem M de Vos; Elaine E Vaughan
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

7.  Xylo-oligosaccharides and virginiamycin differentially modulate gut microbial composition in chickens.

Authors:  Mohsen Pourabedin; Leluo Guan; Xin Zhao
Journal:  Microbiome       Date:  2015-04-10       Impact factor: 14.650

Review 8.  Plant cell wall polysaccharides as potential resources for the development of novel prebiotics.

Authors:  Hye-Dong Yoo; Dojung Kim; Seung-Ho Paek
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634

Review 9.  Potential Valorization of Hazelnut Shells through Extraction, Purification and Structural Characterization of Prebiotic Compounds: A Critical Review.

Authors:  Andrea Fuso; Davide Risso; Ginevra Rosso; Franco Rosso; Federica Manini; Ileana Manera; Augusta Caligiani
Journal:  Foods       Date:  2021-05-26

10.  Effects of rice bran oil on the intestinal microbiota and metabolism of isoflavones in adult mice.

Authors:  Motoi Tamura; Sachiko Hori; Chigusa Hoshi; Hiroyuki Nakagawa
Journal:  Int J Mol Sci       Date:  2012-08-17       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.